Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P25+2-2+0+0
S51-0+0+0+0

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

M
2017-03-22
BGNEBeigene, Ltd.Wang XiaodongDirS - Sale$36.96-38,10712,826,5740%-$1,408,612
D
2017-03-23
BDSIBiodelivery Sciences International IncVasisht NirajSVP, CTOS - Sale+OE$1.90-530272,4130%-$1,007
D
2017-03-23
BDSIBiodelivery Sciences International IncOdonnell Francis E JrDirS - Sale+OE$1.90-750271,2990%-$1,425
D
2017-03-23
BDSIBiodelivery Sciences International IncDe Paolantonio Ernest RobertCFO, Secretary, TreasurerS - Sale+OE$1.90-17096,4640%-$323
2017-03-23
CPIXCumberland Pharmaceuticals IncBonner MichaelCFOP - Purchase$6.42+90012,800+8%+$5,778
2017-03-21
CPIXCumberland Pharmaceuticals IncKrogulski KennethDirP - Purchase$6.53+15,000150,000+11%+$97,950
DM
2017-03-22
EGRXEagle Pharmaceuticals, Inc.Krill Steven L.EVP, Chief Scientific OfficerS - Sale+OE$81.07-14,1250-100%-$1,145,130
2017-03-22
KMPHKempharm, IncMickle Christal M MVP, Operations, Product Dvlp., 10%P - Purchase$4.10+2,0002,387,1450%+$8,199
2017-03-22
KMPHKempharm, IncMickle Travis CPres, CEO, 10%P - Purchase$4.10+2,0002,387,1450%+$8,199
D
2017-03-23
FLXNFlexion Therapeutics IncDriscoll Frederick WCFOS - Sale+OE$23.00-3,0007,777-28%-$69,000
M
2017-03-22
AGIOAgios Pharmaceuticals IncCantley Lewis Clayton Jr.DirS - Sale$53.11-2,036238,560-1%-$108,132
M
2017-03-22
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.22+4,0003,708,2570%+$880
2017-03-22
CALACalithera Biosciences, Inc.Adage Capital Partners Gp, L.L.C.10%P - Purchase$10.25+487,8044,122,873+13%+$4,999,991+1
2017-03-23
MYLMylan N.V.Abbott Laboratories10%S - Sale$41.60-44,000,00025,750,000-63%-$1,830,400,000-2
2017-03-23
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.71+12,200183,941,5560%+$94,024+3
2017-03-23
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.73-22,22313,756,4350%-$38,468
M
2017-03-21
EGRXEagle Pharmaceuticals, Inc.Proquest Investments Iv, L.P.10%S - Sale$83.05-1,2003,811,9380%-$99,657-2
2017-03-21
ESPREsperion Therapeutics, Inc.Janney DanielDirS - Sale$45.80-350,0001,366,987-20%-$16,029,263-4
DM
2017-03-21
SCLNSciclone Pharmaceuticals IncBlobel FriedhelmPres, CEOS - Sale+OE$9.47-40,00092,526-30%-$378,622+2
M
2017-03-21
ESPREsperion Therapeutics, Inc.Goldstein Dov A MdDirS - Sale$41.66-800,000837,125-49%-$33,327,088-4
D
2017-03-22
UTHRUnited Therapeutics CorpThompson Tommy GDirS - Sale+OE$139.37-2,0000-100%-$278,740+1
M
2017-03-21
RGLSRegulus Therapeutics Inc.Papadopoulos SteliosDirP - Purchase$1.22+500,000700,677+249%+$607,900+12
D
2017-03-21
AIMTAimmune Therapeutics, Inc.Desouza Warren L.CFOS - Sale+OE$22.95-10,00020,681-33%-$229,5000
2017-03-23
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.05+9,00019,863,6490%+$483
2017-03-22
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.75-39,95013,778,6580%-$69,797
2017-03-23
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+8,00019,854,6490%+$471
2017-03-22
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+23,00019,846,6490%+$1,320
2017-03-21
XOMAXoma CorpNeal James RVP Business DevelopmentS - Sale$5.40-5,10518,327-22%-$27,569+8
2017-03-21
XOMAXoma CorpBurns Thomas M.VP, Finance, Chief FinancialS - Sale$5.40-2,5988,945-23%-$14,030+8
D
2017-03-20
PAHCPhibro Animal Health CorpCarlson Gerald KDirS - Sale+OE$28.13-12,0000-100%-$337,560+1
D
2017-03-20
MYOKMyokardia IncGianakakos AnastasiosPres, CEOS - Sale+OE$15.00-1,412689,2110%-$21,180+3
2017-03-20
MYOKMyokardia IncBauer JakeSee RemarksS - Sale$15.00-66783,900-1%-$10,005+3
D
2017-03-20
CTLTCatalent, Inc.Downie WilliamSee RemarksS - Sale+OE$28.60-8,26236,665-18%-$236,293-1
DM
2017-03-20
ALKSAlkermes Plc.Cooke ShanePres, Alkermes plcS - Sale+OE$60.09-1,90071,948-3%-$114,162-1
DM
2017-03-20
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$24.34-38,6363,550,549-1%-$940,3050
2017-03-15
BMYBristol Myers Squibb CoCaldarella Joseph CSVP, ControllerS - Sale$57.28-8,09657,389-12%-$463,779-1
D
2017-03-20
NKTRNektar TherapeuticsThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$19.69-112,50055,637-67%-$2,215,125-2
2017-03-21
RDUSRadius Health, Inc.Biotech Growth N V10%P - Purchase$35.83+50,0004,540,399+1%+$1,791,625+1
2017-03-20
CLSDClearside Biomedical, Inc.Shaffer Christy LDirP - Purchase$6.90+2,2002,200New+$15,180+2
M
2017-03-20
ISCOInternational Stem Cell CorpSemechkin AndreyCEO, 10%P - Purchase$1.67+10,0001,578,584+1%+$16,660
D
2017-03-20
AGIOAgios Pharmaceuticals IncBiller ScottChief Scientific OfficerS - Sale+OE$55.00-6,43846,470-12%-$354,090+2
2017-03-21
ADMSAdamas Pharmaceuticals IncWent Gregory TCEOS - Sale$17.03-2,807521,918-1%-$47,8030
2017-03-21
ADMSAdamas Pharmaceuticals IncPatni RajivChief Medical OfficerS - Sale$17.04-73313,642-5%-$12,4900
2017-03-21
ADMSAdamas Pharmaceuticals IncDawson William JCFOS - Sale$17.02-71614,284-5%-$12,1860
2017-03-22
EGRXEagle Pharmaceuticals, Inc.Edlin Richard A.DirP - Purchase$79.44+6,00029,400+26%+$476,640+2
2017-03-20
ARLZAralez Pharmaceuticals Inc.Charles Scott JCFOS - Sale$2.41-5,205208,163-2%-$12,544-4
2017-03-20
ARLZAralez Pharmaceuticals Inc.Koven Andrew IPres, Chief Business OffS - Sale$2.41-7,8251,416,411-1%-$18,858-4
2017-03-21
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+6,00019,823,6490%+$346
2017-03-21
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.75-35,04513,818,6080%-$61,477
2017-03-21
ESPREsperion Therapeutics, Inc.Omenn Gilbert SDirP - Purchase$42.26+1,00011,000+10%+$42,2600
2017-03-21
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.85+5,800183,929,3560%+$45,5310
D
2017-03-20
CTMXCytomx Therapeutics, Inc.Goeltz II Robert C.CFOS - Sale+OE$19.81-21,5179,789-69%-$426,340+2
D
2017-03-20
CTMXCytomx Therapeutics, Inc.McCarthy Sean A.Pres, CEOS - Sale+OE$19.60-14,343160,716-8%-$281,123+2
2017-03-20
LGNDLigand Pharmaceuticals IncHiggins John LCEOS - Sale$109.10-4,000139,171-3%-$436,4000
2017-03-13
EYEGEyegate Pharmaceuticals IncVentech Capital II10%S - Sale$2.80-4,4191,431,8140%-$12,385-4
2017-03-21
EGRXEagle Pharmaceuticals, Inc.Pernock DavidPres, Chief Comm. OfficerP - Purchase$83.98+61511+14%+$5,123+3
2017-03-17
BMYBristol Myers Squibb CoSchmukler Louis SPres, Global Mfg., SupplyS - Sale$56.49-5,00021,483-19%-$282,470+1
2017-03-20
EGLTEgalet CorpShea Patrick MChief Commercial OfficerS - Sale$4.75-4,25038,250-10%-$20,1880
2017-03-20
KMPHKempharm, IncTierney David SDirP - Purchase$4.20+1,0006,000+20%+$4,200+1
M
2017-03-17
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.05+29,20019,817,6490%+$1,451
2017-03-20
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.25+1,0003,704,2570%+$250
2017-03-16
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.74-10,50013,853,6530%-$18,270
2017-03-17
RDUSRadius Health, Inc.Biotech Growth N V10%P - Purchase$38.41+30,0004,490,399+1%+$1,152,249-7
M
2017-03-17
NERVMinerva Neurosciences, Inc.Beer Marc DDirP - Purchase$8.12+50,00050,000New+$405,750-1
2017-03-20
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.99+11,000183,923,5560%+$87,924-2
2017-03-17
FLXNFlexion Therapeutics IncBodick NeilChief Medical OfficerS - Sale$20.41-5,000439,620-1%-$102,039-6+32
M
2017-03-16
BGNEBeigene, Ltd.Oyler JohnCEO, 10%S - Sale$39.39-31,98971,610,3190%-$1,260,073-4-8
D
2017-03-20
MKubota Pharmaceutical Holdings Co LtdScheibler LukasEVP of Research, DevelopmentS - Sale+OE$7.10-1,2505,599-18%-$8,875-3-4
2017-03-16
ZGNXZogenix, Inc.Tannenbaum Renee PDirP - Purchase$11.00+5,00010,000+100%+$55,000-2-1
M
2017-03-16
EGRXEagle Pharmaceuticals, Inc.Proquest Investments Iv, L.P.10%S - Sale$82.06-100,0007,644,308-1%-$8,206,308-7-4
DM
2017-03-16
CTLTCatalent, Inc.Chiminski John RSee RemarksS - Sale+OE$28.62-73,819186,507-28%-$2,112,537-2-1
2017-03-16
CLSDClearside Biomedical, Inc.Cagle Gerald D.DirP - Purchase$6.84+5,00010,941+84%+$34,200+1+2
2017-03-17
JNPJuniper Pharmaceuticals IncGeraghty James ADirP - Purchase$4.82+2,00065,153+3%+$9,6370-2
D
2017-03-16
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$140.16-1,218649,3450%-$170,709-2-1
2017-03-16
CORTCorcept Therapeutics IncEnright Patrick GDirS - Sale$9.94-269,9556,108,328-4%-$2,683,237-4-3
2017-03-16
BPMCBlueprint Medicines CorpLevin Mark J10%S - Sale$40.88-30,0003,564,997-1%-$1,226,412-1+6
2017-03-17
INFIInfinity Pharmaceuticals, Inc.Venuti Michael CDirS - Sale$3.48-6,25050,000-11%-$21,750-6-2
A
2017-02-17
REPHRecro Pharma, Inc.Scp Vitalife Partners II LP10%S - Sale$7.59-9,9832,292,8390%-$75,791-1-1
AM
2017-03-14
REPHRecro Pharma, Inc.Scp Vitalife Partners II LP10%S - Sale$8.00-44,9772,247,862-2%-$359,992-1-1
AM
2017-02-14
REPHRecro Pharma, Inc.Scp Vitalife Partners II LP10%S - Sale$7.89-12,0652,302,822-1%-$95,171-1-1
M
2017-02-28
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.02+15,80019,788,4490%+$251
2017-03-17
RXIIRxi Pharmaceuticals CorpCauwenbergh GeertPres, CEOP - Purchase$0.77+10,000107,533+10%+$7,692-3-6
2017-03-17
CRBPCorbus Pharmaceuticals Holdings, Inc.White BarbaraChief Medical OfficerP - Purchase$9.49+4,233166,300+3%+$40,171+8-5
2017-03-17
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$8.19+9,000183,912,5560%+$73,710-1-3
D
2017-03-16
XNCRXencor IncKuch John JVP, FinanceS - Sale+OE$24.42-15,00077,171-16%-$366,278+1-2
2017-03-16
BMRNBiomarin Pharmaceutical IncDavis George EricEVP, GCS - Sale$91.96-2,23873,729-3%-$205,806-1-4
2017-03-15
XNCRXencor IncDesjarlais John RSVP, Research, CSOS - Sale$24.47-13,75587,676-14%-$336,637+1-2
2017-03-16
BMRNBiomarin Pharmaceutical IncSpiegelman Daniel KEVP, CFOS - Sale$91.96-1,98914,471-12%-$182,908-1-4
DM
2017-03-15
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$91.69-10,000373,475-3%-$916,900-1-4
D
2017-03-15
OMEDOncomed Pharmaceuticals IncHager Alicia J.SVP, GCS - Sale+OE$10.00-6,65225,877-20%-$66,520-3-8
M
2017-03-16
VSARVersartis, Inc.Malik ShahzadDirS - Sale$18.11-483,6701,630,758-23%-$8,758,575+8+8
D
2017-03-16
SCLNSciclone Pharmaceuticals IncXie LanVP Finance, China CFOS - Sale+OE$9.60-1,0000-100%-$9,600+4+1
D
2017-03-15
SCLNSciclone Pharmaceuticals IncZhao HongCEO, China OperationsS - Sale+OE$9.60-3,0000-100%-$28,800+4+1
2017-03-15
KINKindred Biosciences, Inc.Park West Asset Management LLC10%P - Purchase$6.60+400,0004,386,404+10%+$2,640,000+3+1
M
2017-03-15
CLSDClearside Biomedical, Inc.Thorp ClayDir, 10%S - Sale$6.56-68,4854,057,364-2%-$449,5430+2
2017-03-15
ARLZAralez Pharmaceuticals Inc.Koven Andrew IPres, Chief Business OffP - Purchase$2.55+20,0001,424,236+1%+$50,920+5-1
2017-03-15
ARLZAralez Pharmaceuticals Inc.Lee Kenneth B JrDirP - Purchase$2.52+5,00095,452+6%+$12,619+5-1
2017-03-15
ARLZAralez Pharmaceuticals Inc.Rudnick SethDirP - Purchase$2.26+15,000109,391+16%+$33,950+5-1
2017-03-15
ARLZAralez Pharmaceuticals Inc.Kirsch Arthur SDirP - Purchase$2.27+45,000154,109+41%+$102,249+5-1
2017-03-15
ARLZAralez Pharmaceuticals Inc.Adams AdrianCEOP - Purchase$2.46+500,0003,569,230+16%+$1,230,950+5-1

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top